Table 1 Drug sensitivity analysis of TLX2.

From: Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer

Compound

Source

Spearman rho

Spearman.fdr

P value

Rutacridone epoxide

CellMiner

0.472

0.021

0.00014

Vicenistatin

CellMiner

0.420

0.022

0.00085

n8-Actinomycin d

CellMiner

0.400

0.040

0.0015

Calcein am

CellMiner

0.394

0.027

0.0018

Thymophthalein

CellMiner

0.377

0.028

0.003

Y-39983

GDSC

ā€‰āˆ’ā€‰0.162

 < 0.001

 < 0.001

CX-5461

GDSC

ā€‰āˆ’ā€‰0.164

 < 0.001

 < 0.001

VNLG/124

GDSC

ā€‰āˆ’ā€‰0.167

 < 0.001

 < 0.001

Navitoclax

GDSC

ā€‰āˆ’ā€‰0.178

 < 0.001

 < 0.001

Indole-2,3-dione, 3-[(o-nitrophenyl)hydrazone]

CellMiner

ā€‰āˆ’ā€‰0.407

0.029

0.0013